Skip to content

Revvity RVTY Diagnostics — Goodwill, Acquisition

Other segment segments

Life Sciences
$32.04M

Similar metrics at other companies

Labcorp Holdings logo
LHDiagnostics — Goodwill
$5.61B
Agilent Technologies logo
ADiagnostics and Genomics — Goodwill
$2.64B+24.1%
Labcorp Holdings logo
LHDiagnostics — Goodwill acquired, excluding measurement period adjustments
$146.6M
Agilent Technologies logo
ALife Sciences and Diagnostics Markets — Goodwill
$3B-0.1%
Labcorp Holdings logo
LHLabCorp Diagnostics — Goodwill
$5.13B+3.7%
Agilent Technologies logo
ADiagnostics and Genomics — Indefinite-lived Intangible Assets, Purchase Accounting Adjustments
-$2.75M

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept revv:GoodwillAcquisition.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's diagnostics — goodwill, acquisition.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's diagnostics — goodwill, acquisition?
Revvity (RVTY) reported diagnostics — goodwill, acquisition of $0 in Q1 2026.
What does diagnostics — goodwill, acquisition mean?
The value of intangible assets acquired through business purchases in the diagnostics segment.
How do you interpret diagnostics — goodwill, acquisition?
An increase suggests active inorganic growth strategy, while significant write-downs may signal overpayment or declining business value.
How does diagnostics — goodwill, acquisition compare across companies?
Standard line item for companies pursuing M&A strategies in the healthcare and diagnostics sectors.